BlackRock, Inc. 13D and 13G filings for Editas Medicine, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-24 2:27 pm Purchase | 2023-12-31 | 13G | Editas Medicine, Inc. EDIT | BlackRock Inc. BLK | 7,838,969 9.600% | 500,227 (+6.82%) | Filing |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | Editas Medicine, Inc. EDIT | BlackRock Inc. BLK | 7,338,742 10.700% | 0 (Unchanged) | Filing |
| 2023-01-20 3:00 pm Purchase | 2022-12-31 | 13G | Editas Medicine, Inc. EDIT | BlackRock Inc. BLK | 7,338,742 10.700% | 355,967 (+5.10%) | Filing |
| 2022-10-07 2:58 pm Purchase | 2022-09-30 | 13G | Editas Medicine, Inc. EDIT | BlackRock Inc. BLK | 6,982,775 10.200% | 1,549,399 (+28.52%) | Filing |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | Editas Medicine, Inc. EDIT | BlackRock Inc. BLK | 5,433,376 7.900% | 127,970 (+2.41%) | Filing |
| 2021-01-29 09:56 am Purchase | 2020-12-31 | 13G | Editas Medicine, Inc. EDIT | BlackRock Inc. BLK | 5,305,406 8.500% | 1,064,208 (+25.09%) | Filing |